Results 41 to 50 of about 234,919 (306)

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

, 2017
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
ALVARO, Domenico, Bellesia, Annamaria, Brambilla, Gianfranco, Bresci, Giampaolo, Dâ€TMangelo, Audenzio, De Francesco, Vincenzo, Di Ciaula, Agostino, Eramo, Annarita, Londoni, Claudio, Manta, Raffaele, Portincasa, Piero, Ridola, Lorenzo, Sacco, Rodolfo, Scaccianoce, Giuseppe, Tanzilli, Anna, Vassallo, Roberto, Zullo, Angelo   +16 more
core   +2 more sources

Epidemiology of Helicobacter pylori infection in dyspeptic Ghanaian patients

The Pan African Medical Journal, 2015
INTRODUCTION: Helicobacter pylori is a gram-negative urease-producing bacteriumcausally linked with gastritis, peptic ulcer disease and gastric adenocarcinoma.
Timothy Nii Akushe Archampong, Richard Harry Asmah, Edwin Kwame Wiredu, Richard Kwasi Gyasi, Kofi Nyaako Nkrumah, Kumar Rajakumar   +5 more
doaj   +1 more source

IDENTIFICACIÓN DE HELICOBACTER PYLORI A PARTIR DE LESIÓN ATEROSCLERÓTICA CORONARIA HUMANA

Biociencias, 2019
Introducción: El principal mecanismo patogénico que subyace la génesis y desarrollo de enfermedades del sistema circulatorio es la aterosclerosis. Es un proceso patológico complejo y progresivo de la pared arterial que afecta especialmente a las arterias
Franklin E. Torres, José Luis Villarreal   +1 more
doaj   +1 more source

Treatment of helicobacter pylori infection in atrophic gastritis [PDF]

, 2018
Helicobacter pylori (Hp) is a major human pathogen causing chronic, progressive gastric mucosal damage and is linked to gastric atrophy and cancer. Hp-positive individuals constitute the major reservoir for transmission of infection.
Annibale, B, Carabotti, M, Lahner, E
core   +1 more source

The evolution of SARS-CoV-2 and the COVID-19 pandemic [PDF]

PeerJ, 2023
Scientists have made great efforts to understand the evolution of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) to provide crucial information to public health experts on strategies to control this viral pathogen.
Yuanfang Si, Weidong Wu, Xia Xue, Xiangdong Sun, Yaping Qin, Ya Li, Chunjing Qiu, Yingying Li, Ziran Zhuo, Yang Mi, Pengyuan Zheng   +10 more
doaj   +2 more sources

Functional plasticity in the type IV secretion system of Helicobacter pylori. [PDF]

, 2012
Helicobacter pylori causes clinical disease primarily in those individuals infected with a strain that carries the cytotoxin associated gene pathogenicity island (cagPAI).
Barrozo, Roberto M, Cariaga, Taryn A, Cooke, Cara L, Cover, Timothy L, Gaddy, Jennifer A, Hansen, Lori M, Johnson, Elizabeth M, Lam, Anna M, Peek, Richard M, Solnick, Jay V, Suarez, Giovanni   +10 more
core   +1 more source

Detection of Helicobacter-like organisms in Thoroughbred horses from Venezuela

Brazilian Journal of Veterinary Pathology, 2010
The aim of this study was to detect the presence of Helicobacter infection in Thoroughbred in Venezuela. One hundred and thirty six Thoroughbreds with signs for Equine gastric ulcer syndrome (EGUS) were studied in the National Race Track La Rinconada ...
Abelardo Morales Briceño, Francisco Garcia, Victor Bermudez   +2 more
doaj   +1 more source

Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis. [PDF]

, 2013
Caveolin-1 (Cav1) is a scaffold protein and pathogen receptor in the mucosa of the gastrointestinal tract. Chronic infection of gastric epithelial cells by Helicobacter pylori (H. pylori) is a major risk factor for human gastric cancer (GC) where Cav1 is
A Bist, A Lee, A Muller, AB Rogers, AS Day, B Razani, C Pelz, C Wunder, CG Hansen, CH Kuo, CH Lai, CH Lai, Christoph Röcken, Claus Schäfer, CM Rosenberger, D Engel, D Forman, D Makola, DW Zaas, E Burgermeister, E Burgermeister, E Burgermeister, E Prade, E Touati, E Touati, Elke Burgermeister, F Lian, F Sommer, FA Medina, FA Medina, FA Medina, Florian Anderl, FS Machado, G Li, G Soong, Gang Yuan, I Mercier, I Regel, IC Arnold, IC Arnold, IC Arnold, IM Toller, Ivana Hitkova, J Li, J Millan, JC Atherton, JE Crabtree, JG Fox, JH Chidlow Jr, JP Boettcher, JS Low, JW Yam, K Ohnuma, K Simons, K Yuan, KM Bourzac, LJ Thompson, M Beigier-Bompadre, M Gadjeva, M Hatakeyama, M Kurayoshi, M Mohammadi, M Yamaga, Markus Gerhard, Matthias P. A. Ebert, MF Dixon, MJ Zhang, ML Hutton, MM D'Elios, MP Ebert, MP Ebert, MR Amieva, NE van Doorn, OA Senkovich, P Gargalovic, P Kundu, P Lajoie, PU Le, R Palovuori, R Rad, R Tsutsumi, Roger Vogelmann, Roland M. Schmid, S Li, S Moese, S Thomas, Simone Reu, Steven R. Blanke, T Kawazoe, T Tomassian, TH Tsai, Thomas Kirchner, TI Jeon, TM Williams, TM Williams, TY Kim, VM Pietiainen, W Schraw, X Cao, X Xing, Y Churin, Y Mitsuno, Y Yamaoka, YC Liao   +103 more
core   +4 more sources

Helicobacter pylori and Extragastric Diseases – Other Helicobacters [PDF]

Helicobacter, 2005
ABSTRACTThe involvement of Helicobacter pylori in the pathogenesis of extragastric diseases continues to be an interesting topic in the field of Helicobacter‐related pathology.Although conflicting findings have been reported for most of the disorders, a role of H.
Nilsson, Ho, Pietroiusti, A, Gabrielli, Maurizio, Zocco, Maria Assunta, Gasbarrini, Giovanni Battista, Gasbarrini, Antonio   +5 more
openaire   +10 more sources

The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study [PDF]

, 2013
<p>Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment.
AJ Lastovica, Andy R. Barclay, B Hope, BL Williams, C Huttenhower, Charlotte E. Nicholl, CP Tamboli, D Laharie, D Linton, Dagmar Kastner-Cole, Diana M. Flynn, E El-Omar, EI Benchimol, Emad M. El-Omar, Gamal Mahdi, Georgina L. Hold, GL Hold, HM Wexler, I Mukhopadhya, I Mukhopadhya, I Mukhopadhya, Indrani Mukhopadhya, J Qin, J Van Limbergen, JE Lennard-Jones, JG Fox, JI Keenan, JL Benach, JL Round, JM Thomson, John M. Thomson, Jon Bishop, Karin A. Saunders, L Jostins, L Zhang, L Zhang, M Grehan, M Grehan, M Imielinski, M Kverka, MP Kronman, NO Kaakoush, P Henderson, Paraic McGrogan, PB Eckburg, R Hansen, R Hansen, R Hansen, Richard Hansen, Richard K. Russell, S Kugathasan, Sabarinathan Loganathan, SJ Bell, SK Lathrop, SM Collins, SM Man, SM Man, SM Man, Stefan Bereswill, Susan H. Berry, SY Shaw, URM Bohr, V Mahendran, W. Michael Bisset   +63 more
core   +8 more sources